Breaking the Silos: Why Your "Pre-Veeva" Workflow Needs an Upgrade

In the pharmaceutical content supply chain, there is a massive gap between the "Brief" and "Approval."

We have excellent systems for the end of the process (Veeva Vault) and excellent systems for strategy (Briefs). But the middle part—the Content Creation phase—is often a mess of Word documents, email threads, and disjointed PDF comments.

Recent industry polls highlight the cost of this disorganization: * 32% of respondents cite "Siloed processes" as their biggest frustration. * 34% complain about "Endless rounds of internal stakeholder coordination."

The "Pre-MLR" Void

Most organizations treat the Medical Legal Review (MLR) as the place where quality control happens. The problem? MLR is expensive.

Using your Medical Director or Regulatory Lead to catch basic formatting errors or missing references is a misuse of high-value resources. As one industry expert noted in a recent discussion on content operations:

"Garbage in, compliance out... Good preparation by commercial colleagues (aligning claims in advance, attaching correct references) will drastically reduce review time."

The Modular Future

The industry is moving toward Modular Content and Dynamic Assembly. The goal is to create content blocks that can be reused across channels without re-approval.

However, you cannot have modular content without modular compliance. If you break a brochure into 10 social media posts, the references must travel with those text blocks perfectly. Manual copy-pasting breaks these links, leading to compliance risks and version control nightmares.

How PharmaText.ai Fits In

We built PharmaText to sit upstream of Veeva. We are the workspace where the "messy" work of drafting happens—but with guardrails.

By using AI to handle the heavy lifting of citation formatting and claim verification during the drafting phase, we ensure that: 1. Commercial Teams (and agencies) can move fast and self-correct before submission. 2. Medical Teams receive clean, referenced drafts that are ready for final sign-off. 3. Silos Break Down because both sides are looking at the same "Single Source of Truth"—the validated references.

Don't let your "Pre-MLR" phase be a black box. unexpected delays. Optimize the draft, and the approval will follow.